期刊文献+

去铁胺对K562细胞多药耐药基因MDR1及核因子κB表达的影响 被引量:2

Effect of desferioxamine on the expression of multidrug resistance gene 1 and nuclear factor κB in K562 cells
下载PDF
导出
摘要 目的探讨去铁胺对柔红霉素(DNR)诱导多药耐药基因MDR1及核因子κB(NFκB)表达的影响,初步了解NFκB与MDR1表达、细胞内铁代谢的关系。方法以DNR单用或联合应用25μmol/L去铁胺(DFO)为处理因素作用于人红白血病细胞株K562,应用RTPCR法、流式细胞分析技术分别检测对照组、DNR组和DNR+DFO组K562细胞MDR1mRNA和P糖蛋白(Pgp)的表达情况,同时采用免疫组织化学染色法检测NFκB的表达及活性情况。结果与对照组相比,DNR可同时诱导MDR1mRNA、Pgp表达和NFκB活化(P<0.05);25μmol/LDFO联合DNR可显著抑制DNR诱导的MDR1mRNA、Pgp的表达及NFκB的活化(P<0.05)。结论去铁胺可减少柔红霉素诱导的MDR1、Pgp表达,其机制可能与铁剥夺后降低了柔红霉素诱导的K562细胞的氧化应激反应,进而影响NFκB的活化有关。 Objectives To investigate the effect of desferioxamine (DFO) on the expression multidrug resistance gene 1 (MDR1), the activation of nuclear factor KB (NFKB) in I(562 cells induced by daunorubicin (DNR), and to study their relationships with intracellular iron metabolism. Methods Reverse transcription-PCR and flow cytometry were used to detect the mRNA expression level of MDR1 and P- glycoprotein (Pgp) in K562 ceils treated with DNR only or DNR associated with 25 μmol/L iron chelator DFO. The expression and activation of NFκB were determined by immunocytochemistry. Untreated K562 cells were used as control. Results Compared to the control group, the expression of MDR1 and the activation of NFκB were induced by DNR (P 〈 0.05) . The addition of 25 μmol/L DFO significantly inhibited the expression of MDR1 and Pgp and the activation of NFκB induced by DNR (P 〈 0.05) . Conclusions Desferioxamine could decrease the expression of MDR1 and Pgp in K562 cells induced by DNR. Iron deprivation might have suppressed the reactions to oxidative stress and subsequently affected the activation of NFκB.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2007年第1期47-50,57,共5页 Journal of Clinical Pediatrics
关键词 白血病 多药耐药基因 去铁胺 核因子ΚB leukemia muhidrug resistance gene 1 desferioxamine nuclear factor κB
  • 相关文献

参考文献2

二级参考文献2

共引文献43

同被引文献44

  • 1贾国存,高举,廖清奎,李丰益,袁粒星,何斌.白血病细胞可变铁池的检测及其意义[J].中国实验血液学杂志,2006,14(3):468-470. 被引量:2
  • 2张秋堂,王叨,刘玉峰.铁对白血病细胞HL-60线粒体膜电位及凋亡的影响[J].实用儿科临床杂志,2006,21(15):998-999. 被引量:5
  • 3汤有才,赵春,贾国存,李丰益,廖清奎,牛文忠,王军.铁剥夺对K562细胞凋亡及细胞周期的影响[J].郑州大学学报(医学版),2006,41(6):1055-1057. 被引量:2
  • 4张景,刘元明,张薇,王贝晗,郝钦芳,刘爱兵.血清铁蛋白测定对几种恶性肿瘤的诊断价值[J].武警医学,2007,18(1):74-75. 被引量:15
  • 5张传新,李社军,贾国存,刘玉峰.不同铁状态下HL-60细胞中IRP_2 mRNA的表达[J].肿瘤基础与临床,2007,20(4):299-300. 被引量:1
  • 6Selig RA, White L, Gramacho G, et al. Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts. Cancer Res, 1998; 58(3): 473-478.
  • 7Damell G, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III : the effect of the ligands on molecular targets involved in proliferation. Blood, 1999; 94(2) : 781 -792.
  • 8Rakba N, Loyer P, Gilot D, et al. Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differen- tiated human hepatoma cell lines. Carcinogenesis, 2000; 21 (5) : 943 - 951.
  • 9Gao J, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. IV: The mechanisms involved in inhibiting cell-cycle progression. Blood, 2001 ; 98(3) : 842 -850.
  • 10Lovejoy DB, Richardson DR. Novel "hybrid" iron chelators derived from aroyl-hydrazones and thiosemicarbazones demonstrate selective antipmliferative activity against tumor cells. Blood, 2002 ; 100(2) : 666 -676.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部